Claudine Brisard

543 total citations
6 papers, 265 citations indexed

About

Claudine Brisard is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Claudine Brisard has authored 6 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Experimental and Cognitive Psychology and 3 papers in Psychiatry and Mental health. Recurrent topics in Claudine Brisard's work include Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Tryptophan and brain disorders (2 papers). Claudine Brisard is often cited by papers focused on Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Tryptophan and brain disorders (2 papers). Claudine Brisard collaborates with scholars based in Canada, United Kingdom and France. Claudine Brisard's co-authors include Karen A. Tourian, Stuart Montgomery, P Boyer, Jean‐Michel Germain, Ulla Lepola, James Groark, S. Krishna Padmanabhan, B. Pitrosky, Daniel Z. Lieberman and Krishna Padmanabhan and has published in prestigious journals such as Alzheimer s & Dementia, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Clinical Therapeutics.

In The Last Decade

Claudine Brisard

6 papers receiving 257 citations

Peers

Countries citing papers authored by Claudine Brisard

Since Specialization

Citations

This map shows the geographic impact of Claudine Brisard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudine Brisard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudine Brisard more than expected).

Fields of papers citing papers by Claudine Brisard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudine Brisard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudine Brisard. The network helps show where Claudine Brisard may publish in the future.

Co-authorship network of co-authors of Claudine Brisard

This figure shows the co-authorship network connecting the top 25 collaborators of Claudine Brisard. A scholar is included among the top collaborators of Claudine Brisard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudine Brisard. Claudine Brisard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder 2010 ·Journal of Clinical Psychopharmacology ·Karl Rickels, Stuart Montgomery, Karen A. Tourian, J Guelfi, B. Pitrosky, (unknown), (unknown), (unknown), Claudine Brisard	28
2	P1‐457: Safety, tolerability, and preliminary efficacy of SAM‐531, a 5HT‐6 antagonist, in subjects with mild‐to‐moderate Alzheimer's disease: Results from a phase 2a study 2010 ·Alzheimer s & Dementia ·Claudine Brisard, Beth Safirstein, Kevin Booth, (unknown), Y. Brault, Sangeeta Raje, Steven M. Leventer	6
3	Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies 2009 ·Clinical Therapeutics ·Karen A. Tourian, S. Krishna Padmanabhan, James Groark, Claudine Brisard, (unknown)	61
4	Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial 2008 ·International Clinical Psychopharmacology ·P Boyer, Stuart Montgomery, Ulla Lepola, Jean‐Michel Germain, Claudine Brisard, (unknown), (unknown), Karen A. Tourian	108
5	A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder 2008 ·International Clinical Psychopharmacology ·Daniel Z. Lieberman, Stuart Montgomery, Karen A. Tourian, Claudine Brisard, (unknown), Krishna Padmanabhan, (unknown), B. Pitrosky	50
6	Bipolar disorder 2007 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Gérard Emilien, (unknown), Claudine Brisard, Emmanuelle Corruble, Michel Bourin	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact